Low serum albumin levels and high neutrophil counts are predictive of a poorer prognosis in patients with metastatic breast cancer
暂无分享,去创建一个
[1] Luan Xue,et al. The potential value of fibrinogen to albumin ratio (FAR) in the assessment of inflammation in spondyloarthritis , 2022, BMC Musculoskeletal Disorders.
[2] Stewart G. Martin,et al. In vitro radiosensitization of breast cancer with hypoxia‐activated prodrugs , 2022, Journal of cellular and molecular medicine.
[3] B. Czerniecki,et al. Effect of Microporous Polysaccharide Particles in Patients Undergoing Mastectomy. , 2022, Clinical breast cancer.
[4] J. Morote,et al. Definition of Castrate Resistant Prostate Cancer: New Insights , 2022, Biomedicines.
[5] N. Normanno,et al. Lurbinectedin for small cell lung cancer , 2021, Frontiers in Oncology.
[6] Sarah A. Frye,et al. SNMMI Clinical Trials Network Research Series for Technologists: Ethical Issues and Regulations in the Medical Workplace , 2021, Journal of Nuclear Medicine Technology.
[7] Zechang Xin,et al. Development and validation of a nomogram to predict drainage duration in patients with breast cancer treated with modified radical mastectomy , 2021, Scientific Reports.
[8] Takanobu Yamada,et al. The Prognostic Value of the Perioperative Systemic Inflammation Score for Patients With Advanced Gastric Cancer , 2020, AntiCancer Research.
[9] C. González-Espinosa,et al. Mast Cells Localize in Hypoxic Zones of Tumors and Secrete CCL-2 under Hypoxia through Activation of L-Type Calcium Channels , 2020, The Journal of Immunology.
[10] B. Han,et al. Retracted Article: Overexpression of circ_0034642 contributes to hypoxia-induced glycolysis, cell proliferation, migration and invasion in gliomas by facilitating TAGLN2 expression via sponging miR-625-5p , 2020, RSC advances.
[11] Yi-Shan Chen,et al. In-depth mining of clinical data: the construction of clinical prediction model with R. , 2019, Annals of translational medicine.
[12] Hanjoe Kim. Propensity Score Analysis in Non-Randomized Experimental Designs: An Overview and a Tutorial Using R Software. , 2019, New directions for child and adolescent development.
[13] Zhuxian Zhou,et al. Drug-binding albumins forming stabilized nanoparticles for efficient anticancer therapy. , 2019, Nanomedicine : nanotechnology, biology, and medicine.
[14] M. Calero,et al. Multifunctional Albumin-Stabilized Gold Nanoclusters for the Reduction of Cancer Stem Cells , 2019, Cancers.
[15] M. Karin,et al. The Fire within: Cell-Autonomous Mechanisms in Inflammation-Driven Cancer. , 2019, Cancer cell.
[16] Vanessa M. Hubbard-Lucey,et al. Immunotherapy and targeted therapy combinations in metastatic breast cancer. , 2019, The Lancet. Oncology.
[17] J. Xie,et al. Docetaxel-loaded human serum albumin (HSA) nanoparticles: synthesis, characterization, and evaluation , 2019, BioMedical Engineering OnLine.
[18] [A consensus statement on the breast-conserving surgery of early-stage breast cancer (2019)]. , 2019, Zhonghua wai ke za zhi [Chinese journal of surgery].
[19] H. L. Wright,et al. Neutrophils and redox stress in the pathogenesis of autoimmune disease. , 2018, Free radical biology & medicine.
[20] C. Duvall,et al. Harnessing albumin as a carrier for cancer therapies , 2018, Advanced drug delivery reviews.
[21] A. Mantovani. The inflammation – cancer connection , 2018, The FEBS journal.
[22] P. Lin,et al. Mechanisms that drive inflammatory tumor microenvironment, tumor heterogeneity, and metastatic progression. , 2017, Seminars in cancer biology.
[23] Craig L Duvall,et al. Lipophilic siRNA targets albumin in situ and promotes bioavailability, tumor penetration, and carrier-free gene silencing , 2017, Proceedings of the National Academy of Sciences.
[24] K. Endo,et al. C-Reactive Protein/Albumin Ratio and Prognostic Nutritional Index Are Strong Prognostic Indicators of Survival in Resected Pancreatic Ductal Adenocarcinoma , 2017, Journal of pancreatic cancer.
[25] A. Jemal,et al. Cancer statistics, 2017 , 2017, CA: a cancer journal for clinicians.
[26] M. Levy,et al. Role of albumin in diseases associated with severe systemic inflammation: Pathophysiologic and clinical evidence in sepsis and in decompensated cirrhosis. , 2016, Journal of critical care.
[27] Xiaoyuan Chen,et al. Simple bioconjugate chemistry serves great clinical advances: albumin as a versatile platform for diagnosis and precision therapy. , 2016, Chemical Society reviews.
[28] Jie Chen,et al. Low pretreatment serum globulin may predict favorable prognosis for gastric cancer patients , 2016, Tumor Biology.
[29] Tiehong Zhang,et al. Albumin and Neutrophil Combined Prognostic Grade as a New Prognostic Factor in Non-Small Cell Lung Cancer: Results from a Large Consecutive Cohort , 2015, PloS one.
[30] T. Finucane,et al. Serum Albumin and Prealbumin in Calorically Restricted, Nondiseased Individuals: A Systematic Review. , 2015, The American journal of medicine.
[31] J. Gu,et al. Prognostic significance of pretreatment serum levels of albumin, LDH and total bilirubin in patients with non-metastatic breast cancer. , 2015, Carcinogenesis.
[32] Zuyao Yang,et al. Chemotherapy with cetuximab versus chemotherapy alone for chemotherapy-naive advanced non-small cell lung cancer. , 2014, The Cochrane database of systematic reviews.
[33] Xingsheng Wang,et al. Changes of serum albumin level and systemic inflammatory response in inoperable non-small cell lung cancer patients after chemotherapy. , 2014, Journal of cancer research and therapeutics.
[34] M. P. Cohen. Clinical, pathophysiological and structure/function consequences of modification of albumin by Amadori-glucose adducts. , 2013, Biochimica et biophysica acta.
[35] S. Lang,et al. Modulation of neutrophil granulocytes in the tumor microenvironment: mechanisms and consequences for tumor progression. , 2013, Seminars in cancer biology.
[36] M. Radic,et al. Neutrophil Extracellular Traps: Double-Edged Swords of Innate Immunity , 2012, The Journal of Immunology.
[37] T. Whiteside,et al. Tumor‐derived macrophage migration inhibitory factor modulates the biology of head and neck cancer cells via neutrophil activation , 2011, International journal of cancer.
[38] A. Mantovani. The yin-yang of tumor-associated neutrophils. , 2009, Cancer cell.
[39] Patrick Soon-Shiong,et al. Protein nanoparticles as drug carriers in clinical medicine. , 2008, Advanced drug delivery reviews.
[40] J. Grutsch,et al. Is serum albumin an independent predictor of survival in patients with breast cancer? , 2003, JPEN. Journal of parenteral and enteral nutrition.
[41] G. Lyman,et al. Colony stimulating factors for chemotherapy induced febrile neutropenia. , 2003, The Cochrane database of systematic reviews.
[42] A. Wunder,et al. Plasma protein (albumin) catabolism by the tumor itself--implications for tumor metabolism and the genesis of cachexia. , 1997, Critical reviews in oncology/hematology.
[43] R. Coates,et al. Race, nutritional status, and survival from breast cancer. , 1990, Journal of the National Cancer Institute.
[44] F. Bozzetti,et al. Impact of Cancer, Type, Site, Stage and Treatment on the Nutritional Status of Patients , 1982, Annals of surgery.
[45] S. Parlee,et al. This Work Is Licensed under a Creative Commons Attribution-noncommercial 4.0 International License , 2022 .